Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001698203 | SCV000526646 | likely benign | not provided | 2020-12-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001404086 | SCV001605975 | likely benign | Myofibrillar myopathy 4 | 2023-08-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002392999 | SCV002705319 | likely benign | Cardiovascular phenotype | 2022-08-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330671 | SCV004038174 | benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001698203 | SCV005221830 | likely benign | not provided | criteria provided, single submitter | not provided |